Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03148262 · ClinicalTrials.gov registry record · NA
High-Flow Nasal Cannula and Desaturation Episodes in the Morbidly Obese Patients
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 59
- Enrollment target
NCT03148262 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 59 participants.
The verdict
NCT03148262, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
Study Summary
It is standard practice in the United States and many parts of world to perform Gastrointestinal (GI) endoscopy with the patient under deep sedation. Obesity is accepted as a patient specific risk factor for hypoxic events during procedural sedation for GI endoscopic procedures. The Obese population has a higher prevalence of obstructive sleep apnea (OSA) which is characterized by repeated obstruction of the upper airway, and leads to apnea and desaturation. This prospective, randomized study was designed to compare the effectiveness of the high flow nasal cannula and the standard nasal cannula in morbidly obese (BMI \> 40) patients receiving deep intravenous sedation during colonoscopies. This study will assess whether use of the high flow nasal cannula (HFNC) leads to less intraoperative desaturation events compared to the current standard of care.
Interventions
- DEVICE The Comfort Flo system
- DEVICE The Salter nasal cannula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2017-05-10 |
| Est. Completion | 2018-01-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03148262
The ClinicalTrials.gov registry entry for NCT03148262 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which The Comfort Flo system is the first listed.
NCT03148262 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03148262 about?
NCT03148262 is a clinical study titled "High-Flow Nasal Cannula and Desaturation Episodes in the Morbidly Obese Patients". It is standard practice in the United States and many parts of world to perform Gastrointestinal (GI) endoscopy with the patient under deep sedation. Obesity is accepted as a patient specific risk factor for hypoxic events during procedural sedation for GI endoscopic procedures. The Obese population...
What is the current status of trial NCT03148262?
This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2017-05-10. Estimated completion is 2018-01-22.
What interventions are being tested in trial NCT03148262?
The interventions under investigation include: The Comfort Flo system (DEVICE), The Salter nasal cannula (DEVICE).
Who is sponsoring clinical trial NCT03148262?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.